“Evaluating Knowledge And Awareness Of SGLT-2 Inhibitors’ Use, Efficacy, Side Effects, And Cardiovascular And Renal Impacts Among Primary Healthcare Physicians In Makkah, Saudi Arabia” (2025) The Review of Diabetic Studies, pp. 490–500. doi:10.70082/rr96vh76.